From: A robust blood gene expression-based prognostic model for castration-resistant prostate cancer
A. Univariate analysis of validation set I | Â | Â | Â |
---|---|---|---|
 | Concordance index | P value (Likelihood ratio test) | P value (Logrank test) |
Wang_4genescore | 0.81 | 0.0006 | 7×10−05 |
Hemoglobin | 0.75 | 0.001 | 0.001 |
VisceralMetastasis | 0.58 | 0.006 | 1×10−05 |
LDH | 0.72 | 0.043 | 0.016 |
BoneMetastasis | 0.56 | 0.051 | 0.15 |
EosinophilCount | 0.69 | 0.052 | 0.068 |
PSA | 0.62 | 0.12 | 0.066 |
AP | 0.61 | 0.18 | 0.13 |
NLRatio | 0.57 | 0.18 | 0.14 |
MonocyteCount | 0.46 | 0.19 | 0.11 |
PlateletCount | 0.62 | 0.3 | 0.3 |
NeutrophilCount | 0.50 | 0.4 | 0.4 |
Gleason | 0.52 | 0.7 | 0.7 |
LymphocyteCount | 0.59 | 0.7 | 0.7 |
BasophilCount | 0.48 | >0.9 | >0.9 |
B. Multivariate analysis of validation set I | Â | ||
 | P value (Wald’s test) |  |  |
Wang_4genescore | 0.045 | Â | Â |
Hemoglobin | 0.18 | Â | Â |
visceralMets | 0.13 | Â | Â |
LDH | 0.4 | Â | Â |